These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 9122194)
1. The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. Wang Z; Harkins PC; Ulevitch RJ; Han J; Cobb MH; Goldsmith EJ Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2327-32. PubMed ID: 9122194 [TBL] [Abstract][Full Text] [Related]
2. Crystal structure of p38 mitogen-activated protein kinase. Wilson KP; Fitzgibbon MJ; Caron PR; Griffith JP; Chen W; McCaffrey PG; Chambers SP; Su MS J Biol Chem; 1996 Nov; 271(44):27696-700. PubMed ID: 8910361 [TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase. Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991 [TBL] [Abstract][Full Text] [Related]
4. Structural basis of inhibitor selectivity in MAP kinases. Wang Z; Canagarajah BJ; Boehm JC; Kassisà S; Cobb MH; Young PR; Abdel-Meguid S; Adams JL; Goldsmith EJ Structure; 1998 Sep; 6(9):1117-28. PubMed ID: 9753691 [TBL] [Abstract][Full Text] [Related]
5. Atomic structure of the MAP kinase ERK2 at 2.3 A resolution. Zhang F; Strand A; Robbins D; Cobb MH; Goldsmith EJ Nature; 1994 Feb; 367(6465):704-11. PubMed ID: 8107865 [TBL] [Abstract][Full Text] [Related]
6. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Tong L; Pav S; White DM; Rogers S; Crane KM; Cywin CL; Brown ML; Pargellis CA Nat Struct Biol; 1997 Apr; 4(4):311-6. PubMed ID: 9095200 [TBL] [Abstract][Full Text] [Related]
7. Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein Kinase/ERK kinase kinase 3 (MEKK) derivative. Ellinger-Ziegelbauer H; Brown K; Kelly K; Siebenlist U J Biol Chem; 1997 Jan; 272(5):2668-74. PubMed ID: 9006902 [TBL] [Abstract][Full Text] [Related]
8. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. Young PR; McLaughlin MM; Kumar S; Kassis S; Doyle ML; McNulty D; Gallagher TF; Fisher S; McDonnell PC; Carr SA; Huddleston MJ; Seibel G; Porter TG; Livi GP; Adams JL; Lee JC J Biol Chem; 1997 May; 272(18):12116-21. PubMed ID: 9115281 [TBL] [Abstract][Full Text] [Related]
9. Identification of a nuclear export signal in MKK6, an activator of the carp p38 mitogen-activated protein kinases. Hashimoto H; Fukuda M; Matsuo Y; Yokoyama Y; Nishida E; Toyohara H; Sakaguchi M Eur J Biochem; 2000 Jul; 267(14):4362-71. PubMed ID: 10880959 [TBL] [Abstract][Full Text] [Related]
10. Modelling of active forms of protein kinases: p38--a case study. Ginalski K; Lesyng B; Sowadski J; Wojciechowski M Acta Biochim Pol; 1997; 44(3):557-64. PubMed ID: 9511965 [TBL] [Abstract][Full Text] [Related]
11. The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Li Z; Jiang Y; Ulevitch RJ; Han J Biochem Biophys Res Commun; 1996 Nov; 228(2):334-40. PubMed ID: 8920915 [TBL] [Abstract][Full Text] [Related]
12. Active mutants of the human p38alpha mitogen-activated protein kinase. Diskin R; Askari N; Capone R; Engelberg D; Livnah O J Biol Chem; 2004 Nov; 279(45):47040-9. PubMed ID: 15284239 [TBL] [Abstract][Full Text] [Related]
13. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. Slack DN; Seternes OM; Gabrielsen M; Keyse SM J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of the 27-kDa heat shock protein via p38 MAP kinase and MAPKAP kinase in smooth muscle. Larsen JK; Yamboliev IA; Weber LA; Gerthoffer WT Am J Physiol; 1997 Nov; 273(5):L930-40. PubMed ID: 9374719 [TBL] [Abstract][Full Text] [Related]
15. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Kampen GT; Stafford S; Adachi T; Jinquan T; Quan S; Grant JA; Skov PS; Poulsen LK; Alam R Blood; 2000 Mar; 95(6):1911-7. PubMed ID: 10706854 [TBL] [Abstract][Full Text] [Related]
16. Crystallization and preliminary X-ray studies of extracellular signal-regulated kinase-2/MAP kinase with an incorporated His-tag. Zhang F; Robbins DJ; Cobb MH; Goldsmith EJ J Mol Biol; 1993 Oct; 233(3):550-2. PubMed ID: 8411162 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. Jiang Y; Gram H; Zhao M; New L; Gu J; Feng L; Di Padova F; Ulevitch RJ; Han J J Biol Chem; 1997 Nov; 272(48):30122-8. PubMed ID: 9374491 [TBL] [Abstract][Full Text] [Related]
18. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. Gum RJ; McLaughlin MM; Kumar S; Wang Z; Bower MJ; Lee JC; Adams JL; Livi GP; Goldsmith EJ; Young PR J Biol Chem; 1998 Jun; 273(25):15605-10. PubMed ID: 9624152 [TBL] [Abstract][Full Text] [Related]
19. Activity of the MAP kinase ERK2 is controlled by a flexible surface loop. Zhang J; Zhang F; Ebert D; Cobb MH; Goldsmith EJ Structure; 1995 Mar; 3(3):299-307. PubMed ID: 7540485 [TBL] [Abstract][Full Text] [Related]
20. Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38. Lu X; Nemoto S; Lin A J Biol Chem; 1997 Oct; 272(40):24751-4. PubMed ID: 9312068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]